Sildenafil and erectile dysfunction
- 1 June 1999
- journal article
- opinion
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 22 (6) , 486-492
- https://doi.org/10.1007/bf03343595
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- SILDENAFIL, A TYPE-5 CGMP PHOSPHODIESTERASE INHIBITOR, SPECIFICALLY AMPLIFIES ENDOGENOUS cGMP-DEPENDENT RELAXATION IN RABBIT CORPUS CAVERNOSUM SMOOTH MUSCLE IN VITROJournal of Urology, 1998
- Clinical safety of oral sildenafil citrate (VIAGRATM) in the treatment of erectile dysfunctionInternational Journal Of Impotence Research, 1998
- EFFECTS OF SILDENAFIL ON THE RELAXATION OF HUMAN CORPUS CAVERNOSUM TISSUE IN VITRO AND ON THE ACTIVITIES OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ISOZYMESJournal of Urology, 1998
- Identification and Characterization of a Novel Family of Cyclic Nucleotide PhosphodiesterasesJournal of Biological Chemistry, 1998
- Oral Sildenafil in the Treatment of Erectile DysfunctionNew England Journal of Medicine, 1998
- THE EFFECT OF THE SPECIFIC PHOSPHODIESTERASE (PDE) INHIBITORS ON HUMAN AND RABBIT CAVERNOUS TISSUE IN VITRO AND IN VIVOJournal of Urology, 1998
- ORAL PHENTOLAMINE AS TREATMENT FOR ERECTILE DYSFUNCTIONJournal of Urology, 1998
- Fortnightly review: Update on male erectile dysfunctionBMJ, 1998
- A therapeutic taxonomy of treatments for erectile dysfunction: an evolutionary imperativeInternational Journal Of Impotence Research, 1997
- ImpotenceJAMA, 1993